2,5-Dimethoxy-4-isopropylamphetamine (also known as DOiP and DOiPr) is a
psychedelic drug
A drug is any chemical substance other than a nutrient or an essential dietary ingredient, which, when administered to a living organism, produces a biological effect. Consumption of drugs can be via insufflation (medicine), inhalation, drug i ...
of the
phenethylamine and
amphetamine
Amphetamine (contracted from Alpha and beta carbon, alpha-methylphenethylamine, methylphenethylamine) is a central nervous system (CNS) stimulant that is used in the treatment of attention deficit hyperactivity disorder (ADHD), narcolepsy, an ...
chemical classes.
It was first
synthesized by
Alexander Shulgin, and was described in his book ''
PiHKAL
''PiHKAL: A Chemical Love Story'' is a book by Alexander Shulgin and Ann Shulgin published in 1991. The subject of the work is Psychoactive drug, psychoactive phenethylamine Derivative (chemistry), chemical derivatives, notably those that act ...
'' (''Phenethylamines i Have Known And Loved''). Shulgin described DOiPR as being at least an order of magnitude weaker than
DOPR, with doses of 20–30 mg required to produce valid changes in mental state.
Very little data exists about the pharmacological properties, metabolism, and toxicity of DOiP. DOiP substitutes for
DOM in rodent
drug discrimination tests, but is several-fold less
potent than other DOx drugs like
DOM,
DOET, and DOPR, though it is similar in potency to
DOBU.
See also
*
2C-iP
*
2C-T-4
*
DOx
References
Designer drugs
DOx (psychedelics)
Isopropyl compounds
Psychedelic phenethylamines
Serotonin receptor agonists
{{hallucinogen-stub